Trial Profile
A study of unfractionated heparin versus bivalirudin in patients undergoing percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Coronary artery disease
- Focus Adverse reactions
- 09 Jun 2016 New trial record